What changed
$OLLI — WATCHLIST 📊 | 6 MONTHS THESIS
🧭 Conviction: MED
🎯 FQ1 FY2027 (ends Apr) | reported Jun 03 | Rev $659M | EPS $0.91 vs $0.87 🟢 | Margin 10.6%
💡 Consensus modestly underestimated near-term earnings power, but after the beat, estimates are likely reset. The market prices in stable growth, but a variant view is that OLLI's low-price model could outperform if consumer spending weakens further, potentially leading to upward revisions.
🏢 Business Quality: 7/10
📊 Valuation: fair — trailing P/E 19.8x, EV/EBITDA 12.8x on annualized $323M EBITDA, FCF yield just 1.8% on market cap.
🔮 Catalyst: next quarterly earnings report
⚖️ Watchlist: OLLI is a solid business but current entry offers only 1.2:1 reward/risk; wait for a pullback to ~$60 or a catalyst that can drive >$85 to justify a long.